You are here:
Imatinib (Glivec®)
Advice
Recommended for restricted use within the NHS in Scotland.
REASONS FOR ADVICE
Recommended for restricted use within the NHS in Scotland, under the supervision of an oncologist for patients with Kit-positive gastrointestinal stromal tumours (GIST).
Drug Details
| Drug Name: | Imatinib (Glivec®) |
|---|---|
| SMC Drug ID: | 08/02 |
| Manufacturer: | Novartis Pharmaceuticals UK Ltd |
| Indication: | Gastrointestinal stromal tumours |
| BNF Category: | |
| Sub Category: | 8.1 Cytotoxic drugs |
| Submission Type: | Full submission |
| Status: | Restricted |
| Date Advice Published: | 9 August 2002 |